Compound information
- Natural Products
- ZC638398
- Molecular Formula
- C13H17NO4
- Molecular Weight
- 251.115758024 g/mol
- Structure
-
- IUPAC Name
- ethyl (2S)-2-(benzyloxycarbonylamino)propanoate
- InChI
- InChI=1S/C13H17NO4/c1-3-17-12(15)10(2)14-13(16)18-9-11-7-5-4-6-8-11/h4-8,10H,3,9H2,1-2H3,(H,14,16)/t10-/m0/s1
- InChI Key
- LPVIAWIIPLTGFK-JTQLQIEISA-N
- SMILES
- CCOC(=O)[C@H](C)NC(=O)OCc1ccccc1
- Source
- ZINC000001613215
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.63 Å2 | LogP | 2.217 |
LogS | -2.411 | LogD | 2.215 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.006 | Pgp substrate | 0.003 |
HIA | 0.964 | F20 % | 0.988 |
F30 % | 0.838 | Caco-2 | -4.727 |
MDCK | -4.536 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.089 | PPB | 74.491 |
VD | 0.532 | Fu | 0.567 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.945 | CYP1A2 substrate | 0.677 |
CYP2A6 substrate | 0.447 | CYP2B6 substrate | 0.596 |
CYP2C19 inhibitor | 0.816 | CYP2C19 substrate | 0.926 |
CYP2C8 substrate | 0.741 | CYP2C9 inhibitor | 0.098 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.054 |
CYP2D6 substrate | 0.711 | CYP2E1 substrate | 0.294 |
CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 0.915 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.765 | CL | 5.588 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.067 | Hepatotoxicity | 0.487 |
Mutagenicity | 0.025 | Rat Oral Acute Toxicity | 0.005 |
FDAMDD | 0.107 | Skin Sensitization | 0.005 |
Carcinogenicity | 0.004 | Eye Corrosion | 0.004 |
Eye Irritation | 0.186 | Respiratory Toxicity | 0.012 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.669 | IGC50 | 2.965 |
LC50FM | 3.904 | LC50DM | 5.087 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.112 | NR-AR-LBD | 0.197 |
NR-AhR | 0.003 | NR-Aromatase | 0.04 |
NR-ER | 0.222 | NR-ER-LBD | 0.329 |
NR-PPAR-gamma | 0.164 | SR-ARE | 0.039 |
SR-ATAD5 | 0.388 | SR-HSE | 0.092 |
SR-MMP | 0.005 | SR-p53 | 0.014 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.